Cargando…
Rational Design of Constrained Peptides as Protein Interface Inhibitors
The lack of progress in developing targeted therapeutics directed at protein–protein complexes has been due to the absence of well-defined ligand-binding pockets and the extensive intermolecular contacts at the protein–protein interface. Our laboratory has developed approaches to dissect protein–pro...
Autores principales: | Murali, Ramachandran, Zhang, Hongtao, Cai, Zheng, Lam, Lian, Greene, Mark |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8395526/ https://www.ncbi.nlm.nih.gov/pubmed/34449551 http://dx.doi.org/10.3390/antib10030032 |
Ejemplares similares
-
Rational design of Harakiri (HRK)-derived constrained peptides as BCL-x(L) inhibitors
por: Zhang, Peiyu, et al.
Publicado: (2023) -
Rational Design of Peptide-Based Inhibitors Disrupting Protein-Protein Interactions
por: Wang, Xuefei, et al.
Publicado: (2021) -
Constrained α-Helical Peptides as Inhibitors of Protein-Protein and Protein-DNA Interactions
por: Roy, Siddhartha, et al.
Publicado: (2018) -
Constrained Peptides as Miniature Protein Structures
por: Yin, Hang
Publicado: (2012) -
Binding of small molecules at interface of protein–protein complex – A newer approach to rational drug design
por: Gurung, A.B., et al.
Publicado: (2017)